Abstract:Objective To evaluate the chnical effectiveness of cardiac resynchronization therapy (CRT) for refractory heart failure.Methods Twenty-one patients with refractory heart failure received CRT device implantation.The left ventricular electrode lead was implanted via cardiac vein through coronary sinus or by epicardial suture.The effectiveness of CRT was evaluated in terms of NYHA class,exercise tolerance,quality of life,QRS width,LVEF and LVEDD during follow-up period.Pacing parameters were tested,and AV/VV interval was optimized by the guidance of echocardiography.Results CRT devices were successfully implanted in 21 patients.Left ventricular epicardial electrode lead was implanted by suture due to deformation of coronary vein in three patients.The mean Follow-up duration was(9.8 ± 9.5 )months.Three patients died and two patients reinhospitalized during follow-up period.The heart function classification,quality of life and distance of 6 minutes hall walk improved significantly after CRT implantation.The LVEF increased from 0.31 20.06 to 0.37 20.05(P<0.01) ,and improved mitral regurgitation was seen in grade 2.24 ±0.89 to 1.43±0.75(P<0.01)one month after CRT implantation.LVEDD decreased from(71.91 ±8.38 )mm to (68.82 ± 10.80) mm (P<0.05 )at 6 month after-implantation.QRS duration decreased significantly after CRT implantation among CRT responsers[(162.50 ± 24.08 ) ms vs( 142.50 ±19.15 ) ms,P <0.05] ,but not in CRT non-responsers[ ( 148.00 ±10.95)ms vs( 138.00 ±4.47) ms,P>0.05].One patient had left ventricular electrode lead dislocation after 2 months.Pacing parameters of electrode leads were within normal range except one patient with high pacing threshold(6.0 V/1.2 ms).The threshold of epicardial electrode lead in two patients was 0.5 V/0.4 ms and 1.0 V/0.4 ms at 18-month and 26-month follow-up,respectively.Atrio-ventricular,inter-ventricular and intraventricular synchrony was achieved by optimizing AV and VV interval by the guidance of echocardiography for all patients.The total clinical effectiveness of CRT was 76.2%.Conclusion CRT is beneficial to patients with refractory heart failure by recovering the cardiac electric and mechanical synchronization.QRS duration is an important predictive index for CBT effectiveness.

Mechanisms of Cardiac Resynchronization Therapy Ameliorating Failing Heart Function Via Regulating Mi-Tochondrial Calcium Uniporter Expression

THE MECHANICAL EFFECTS OF CARDIAC RESYNCHRONIZATION THERAPY PROMOTING AUTOPHAGY VIA MITOCHONDRIAL CALCIUM UNIPORTER DOWN-REGULATION AND MITOCHONDRIAL DYNAMICS ALTERATION

A Study of Mechanical Optimization Strategy for Cardiac Resynchronization Therapy Based on an Electromechanical Model

Protective Effects of Cardiac Resynchronization Therapy in a Canine Model with Experimental Heart Failure by Improving Mitochondrial Function: a Mitochondrial Proteomics Study

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Clinical Effect of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

A prospective study to evaluate the efficacy of an intracardiac electrogram-based atrioventricular and interventricular intervals optimization method in cardiac resynchronization therapy.

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

Mechanisms of Enhanced Beta-Adrenergic Reserve from Cardiac Resynchronization Therapy

Heart Failure Patients Selection for Cardiac Resynchronization Therapy

Single Photon Emission Computed Tomography Myocardial Perfusion Imaging Guided Left Ventricular Lead Implantation to Improve the Response to Cardiac Resynchronization Therapy:Rationale and Design

The Myocardial Ischemia Evaluated by Real-Time Contrast Echocardiography May Predict the Response to Cardiac Resynchronization Therapy: A Large Animal Study

Cardiac Resynchronization Therapy of Heart Failure

The Value of Myocardial Contrast Echocardiography in Evaluating the Relationship Between Myocardial Perfusion and Cardiac Resynchronisation Therapy: an Animal Study

Clinical application of cardiac resynchronization therapy for refractory heart failure

The new choice of medical or cardiac resynchronization therapy non-responders---cardiac contractility modula-tion therapy

P21-Activated Kinase 3 Aggravates Pathological Cardiac Hypertrophy in Mice

Efficacy research of cardiac resynchronization therapy in heart failure with narrow QRS complexes